grant

Comprehensively mapping the functional and antigenic effects of mutations to the Lassa virus glycoprotein complex

Organization UNIVERSITY OF WASHINGTONLocation SEATTLE, UNITED STATESPosted 1 Aug 2025Deadline 31 Dec 2028
NIHUS FederalResearch GrantFY2025AffectAmino AcidsAntibodiesAntibody ResponseAntibody SpecificityAntibody TherapyAntigensCell BodyCellsCessation of lifeClinical Treatment MoabComplexDNA mutationDataDeathDevelopmentEvolutionFutureGenetic ChangeGenetic defectGenetic mutationGlycoproteinsHumanHumoral ImmunitiesImmune responseInfectionInvestigatorsLassaLassa FeverLassa diseaseLassa fever virusLassa virusLentivirinaeLentivirusLibrariesMapsMastomysMeasurementMeasuresMediatingMembrane Protein GeneMembrane ProteinsMembrane-Associated ProteinsModern ManMonoclonal AntibodiesMutationPersonsPhylogenetic AnalysisPhylogeneticsProtein RegionProteinsResearch PersonnelResearchersRiskRodentRodentiaRodents MammalsSpecificitySurface ProteinsTherapeuticTherapeutic antibodiesTreesVaccinesVariantVariationViralViral DiseasesVirusVirus DiseasesWorkaminoacidantibody based therapiesantibody treatmentantibody-based immunityantibody-based therapeuticsantibody-based treatmentdeep sequencingdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalgenome mutationhost responseimmune system responseimmunogenimmunoresponseinsightinterestmAbsmonoclonal Absmutation scanningmutation screeningneutralizing antibodyneutralizing mAbneutralizing monoclonal antibodiespandemic concernpandemic potentialpandemic riskpandemic threatpolyclonal antibodypressureprospectiveresponsespillover eventtherapeutically effectivevaccine candidatevaccine developmentviral infectionvirus infectionvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary/Abstract
Lassa virus is estimated to cause thousands of human deaths each year, primarily due to spillovers from its

natural host, Mastomys rodents. Efforts to create vaccines and antibody therapeutics must account for the

evolutionary variability of Lassa virus’s glycoprotein complex (GPC), which mediates viral entry into cells and…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Comprehensively mapping the functional and antigenic effects of mutations to the Lassa virus glycoprotein complex — UNIV | Dev Procure